Gonorrhea is caused due to bacterial infection (Neisseria gonorrhoeae) that can be passed from one person to another during sex. Gonorrhea is a sexually transmitted disease (STD) affecting both men and women globally. The gonorrhea bacteria infects cervix, uterus and urethra etc. mucous membranes, which are soft tissues and not covered by skin or outer layer. Changes in urination pattern, pain during sex, unusual discharges from male and female sex organs, bleeding, bumps, and sores, pain in the pelvic or abdominal region, and burning or itching in the vaginal area are some of the most common symptoms of gonorrhea. Long-term pelvic pain, infertility, ectopic pregnancy, proctitis, and prostate gland infection are major complications caused by gonorrhea. Nucleic acid amplification tests (NAAT), direct fluorescent tests, and several others tests are recommended by health care specialists to confirm the gonorrhea disease. According to WHO report, over 10 million people are diagnosed with gonorrhea globally each year. Generally, antibiotics and antibacterial medicines are used to treat gonorrhea.

The global gonorrhea drugs market is expanding significantly due to increasing gonorrhea prevalence. Rise in incidence of unprotected sex has led to an increase in the prevalence gonorrhea. Low voluntary screening rate for the disease is a major restrain of the market. Awareness about gonorrhea infection diagnostic tests is extremely low in countries in Africa. Hence, companies are facing challenges with regard to market penetration in the region. Moreover, several low- and middle-income countries depend on government grants for the provision of rapid diagnostic tests in the event of an epidemic. Therefore, direct reach to customers is weaker in these countries. These factors hamper the market in the region.

The global gonorrhea drugs market can be segmented based on drug type, distribution channel, and region. In terms of drug type, the market can be categorized into sulfonamides, tetracycline, aminopenicillins, and macrolides. Macrolides are a class of antibiotics derived from Saccharopolyspora erythraea bacteria. Erythromycin, clarithromycin, azithromycin, and roxithromycin are the most recommended macrolides. In terms of revenue, the macrolides segment held a significant share of the gonorrhea drug market in 2016. Tetracycline is an antibiotic that fights infection caused by bacteria such as Neisseria gonorrheae and is the second major drug after macrolides.

In terms of distribution channel, the global gonorrhea drugs market can be classified into hospital pharmacies, retail pharmacies, and online pharmacies. Based on revenue, the hospital pharmacies segment held a significant share of the gonorrhea drugs market in 2016.

In terms of region, the global gonorrhea drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the leading market for gonorrhea drugs. In terms of revenue, the U.S. holds a major share of the gonorrhea drugs market in North America. The market in Europe is expanding rapidly due to an increase in the patient population, especially in the U.K. and Germany. The market in Asia Pacific and Latin America is projected to expand significantly in the near future. Developing economies such as China and Japan are anticipated to contribute to the growth of the market in Asia Pacific between 2017 and 2025 due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness.

Key players operating in the global gonorrhea drugs market are Pfizer, Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Eli Lilly and Company, Glenmark Generics Ltd., Dr. Reddy's Laboratories Ltd., Mylan N.V., Hi-Tech Pharmacal Co., Inc., and Lupin Ltd., among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Gonorrhea Drugs Market

Pre Book